Mucormycosis Emerging As a ‘New Worry’ For Healthcare Practi
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A potentially life-threatening fungal infection, mucormycosis can lead to severe complications such as brain infection, vision loss, or even death if left untreated. The incidence of this invasive fungal infection has witnessed a sudden spurt in recent months, particularly among people who have recovered from COVID-19. Healthcare experts are terming it “a new worry” in the COVID-19 scenario.

While the incidence of mucormycosis has traditionally been low in India, cases have seen a sudden rise across various cities recently. People with weakened immune systems are the most at risk from this fungal infection. These include people with diabetes, AIDS, certain cancers and long-term use of steroids.

The use of immunosuppression in transplant recipients, immunomodulatory agents including corticosteroids and different invasive procedures are some of the risk factors associated with an increase in IFIs. However, off late, many hospitals in India have reported the emergence of mucormycosis cases in COVID-19 recovered patients.

Mucormycosis is a rare but serious form of invasive fungal infection. COO, Bharat Serums and Vaccines (BSV), Vishwanath Swarup noted. BSV is indigenously developing and manufacturing anti-fungal medications for the condition. It is the first Indian company to get the regulatory approval of Liposomal Amphotericin B, he said.

According to the company’s issued release, BSV is the first company in India to get a Drugs Controller General of India (DCGI) approval for Liposomal Amphotericin B, the anti-fungal medication used in the treatment of this condition. Treatment of mucormycosis involves a combination of surgical removal of affected tissues and antifungal therapy.

Source:
https://www.expresshealthcare.in/news/mucormycosis-emerging-as-a-new-worry-for-healthcare-practitioners/427709/
Dr. J●●●●●h A●●●●i and 2 other likes this1 share
Like
Comment
Share